Discover 1,106 paid clinical trials in Salt Lake City, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
There are a wide variety of studies currently listed in Salt Lake City, focusing on conditions such as autism, celiac disease, and osteoporosis. The city's leading medical research institutions are actively recruiting participants, providing access to cutting-edge treatments and therapies for both healthy volunteers interested in paid clinical trials and individuals in need of studies for specific health conditions.
Filter
2
Filter results
Results: 1,106
Active & Responsive
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for
Healthy
Location: Salt Lake City UT, Idaho Falls ID, Rexburg ID, Boise ID,
Sponsor: Pfizer
Sex: All
Age: 0 - 49
Code: NCT07160244
Phase 3, Recruiting
Active & Responsive
ASSESS ALL ALS Study
for
Amyotrophic Lateral Sclerosis
Location: Salt Lake City UT, Boise ID, Aurora CO, Phoenix AZ,
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Sex: All
Age: 18+
Code: NCT06578195
Recruiting
Active & Responsive
Metformin for Fibromyalgia Symptoms (INFORM Trial)
for
Fibromyalgia Syndrome
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18 - 70+
Code: NCT05900466
Phase 2, Recruiting
Active & Responsive
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
for
High Risk Pregnancy, Pregnancy Complications,
Location: Salt Lake City UT, Toronto, New York NY
Sponsor: David Ware Branch
Sex: Female
Age: 18 - 40
Code: NCT03152058
Phase 2, Recruiting
Active & Responsive
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
for
Hereditary Hemorrhagic Telangiectasia,
Location: Salt Lake City UT, Aurora CO, Los Angeles CA,
Sponsor: Cure HHT
Sex: All
Age: 0+
Code: NCT06259292
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
for
Intracranial Aneurysm
Location: Salt Lake City UT, Englewood CO, Los Angeles CA,
Sponsor: Medtronic Neurovascular Clinical Affairs
Sex: All
Age: 18 - 70+
Code: NCT02998229
Recruiting
Active & Responsive
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
for
Surgery-Complications, Anesthesia Complication,
Location: Salt Lake City UT, San Francisco CA, Portland OR,
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT05991453
Recruiting
Active & Responsive
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
for
Hereditary Hemorrhagic Telangiectasia (HHT),
Location: Salt Lake City UT, Phoenix AZ, Rochester MN,
Location: Salt Lake City UT, Albuquerque NM, Phoenix AZ,
Sponsor: Abbott Medical Devices
Sex: All
Age: 18+
Code: NCT06526195
Recruiting
Active & Responsive
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for
Mesial Temporal Lobe Epilepsy
Location: Salt Lake City UT, Aurora CO, Phoenix AZ, Sacramento CA,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05135091
Phase 3, Recruiting
Active & Responsive
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
for
Phenylketonuria
Location: Salt Lake City UT, Los Angeles CA, Portland OR, Calgary,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18+
Code: NCT06971731
Phase 3, Recruiting
Active & Responsive
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
for
Ulcerative Colitis
Location: Salt Lake City UT, Sun City AZ, Rapid City SD,
Sponsor: Takeda
Sex: All
Age: 18 - 65
Code: NCT06095128
Recruiting
Active & Responsive
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
for
Fabry Disease
Location: Salt Lake City UT, Los Angeles CA, Minneapolis MN,
Sponsor: UniQure Biopharma B.V.
Sex: Male
Age: 18 - 65
Code: NCT06270316
Phase 1, Phase 2, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer